ArticleScientific reports2026
Paired regional complementarity in diffusion MRI reveals disease-specific microstructural profiles in PD, MSA, and PSP: a feasibility study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Parkinson’s disease (PD) is a prevalent neurodegenerative disorder characterized by tremor, rigidity, bradykinesia, and postural instability. Atypical Parkinsonian syndromes such as progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) share overlapping clinical features, complicating accurate diagnosis. While prior diffusion MRI studies have used large, opaque machine-learning models, this study explored the best two diffusion metrics to differentiate Parkinsonian syndromes. This strategy introduces a compact and interpretable approach tailored for clinically relevant cohort sizes. We retrospectively analyzed diffusion MRI data from 199 patients (PD: 140, PSP: 20, MSA: 39) and constructed age- and sex-matched subsets comprising 40 PD, 20 PSP, and 34 MSA subjects to ensure controlled and balanced group comparisons. Mean diffusivity (MD) and fractional anisotropy (FA) were extracted from twelve predefined brain regions. Deformation-based morphometry and deterministic tractography were also used to map macrostructural and pathway-specific changes. Statistical comparisons and logistic regression with cross-validation assessed discriminatory power. MSA patients exhibited significant atrophy, increased MD, and decreased FA in the cerebellum. PSP showed pronounced changes in the superior cerebellar peduncle and corpus callosum. Putamen, corpus callosum, and cerebellum emerged as key discriminators for PD, PSP, and MSA, respectively. A compact and strategically selected set of diffusion features significantly improved disease differentiation. This study demonstrates that interpretable, region-specific complementarily paired diffusion patterns can robustly distinguish PD, PSP, and MSA, offering a transparent and biologically meaningful framework for differential diagnosis and mechanistic understanding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.